References
- Johnson P, Glennie M. The mechanisms of action of rituximab in the elimination of tumor cells. Semin Oncol. 2003;30:3–8.
- Blombery P, Prince HM, Levinson M, et al. Rituximab-induced immunodysregulatory ileocolitis in a patient with follicular lymphoma. J Clin Oncol. 2011:10;29.
- Ram R, Ben-Bassat I, Shpilberg O, et al. The late adverse events of rituximab therapy: Rare but there! Leuk Lymphoma 2009;50:1083–1095.
- Freeman HJ. Colitis associated with biological agents. World J Gastroenterol. 2012;18:1871–1874.
- El Fassi D, Nielsen CH, Kjeldsen J, et al. Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease. Gut 2008;57:714–715.
- Goetz M, Atreya R, Ghalibafian M, et al. Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis. 2007;13:1365–1368.
- Lipka S, Katz S, Crawford JM. Fulminant Colitis Following Rituximab Therapy. Gastroenterol Hepatol (NY). 2016;12:58–60.
- Fernandez-Blanco I, Cara C, Perez M. De novo fulminant colitis after rituximab therapy on a non-Hodgkin lymphoma. Presented at the United European Gastroenterology Federation 16th United European Gastroenterology Week; 2008 October 18–22; Vienna, Austria.
- Sekkach Y, Hammi S, Elqatni M, et al. Ulcerative colitis: exceptional consequence after rituximab therapy. Ann Pharm Fr. 2011;69:265–269.
- Bhalme M, Hayes S, Norton A, et al. Rituximab-associated colitis. Inflamm Bowel Dis. 2013;19: E41–E43.
- Ardelean DS, Gonska T, Wires S, et al. Severe ulcerative colitis after rituximab therapy. Pediatrics 2010;126:e243–e246.
- Mizoguchi E, Mizoguchi A, Preffer FI, et al. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol. 2000;12:597–605.
- Mizoguchi A, Mizoguchi E, Smith RN, et al. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med. 1997;186:1749–1756.
- Mizoguchi A, Mizoguchi E, Takedatsu H, et al. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity. 2002;16:219–230.
- Jamin C, Morva A, Lemoine S, et al. Regulatory B lymphocytes in humans: a potential role in autoimmunity. Arthritis Rheum. 2008;58:1900–1906.